Literature DB >> 25515752

Glutathione-triggered drug release from nanostructures.

Alfonso Latorre, Álvaro Somoza1.   

Abstract

The delivery of drugs can be improved with the use of different carriers, such as those based on nanoparticles. The nanostructures loaded with the therapeutic molecules should be able to reach the target cells and, what is more, release the drugs efficiently. Ideally, the drugs should be delivered only in the target cells, and not along their way to the cells. For these reasons several approaches have been developed to control the release of the drugs at the desired sites. In this review article we have summarized the reports that describe the use of glutathione to trigger the release of the therapeutic molecules from different nanostructures.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25515752     DOI: 10.2174/1568026614666141215143659

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  4 in total

1.  Improving Photodynamic Therapy Anticancer Activity of a Mitochondria-Targeted Coumarin Photosensitizer Using a Polyurethane-Polyurea Hybrid Nanocarrier.

Authors:  Joaquín Bonelli; Enrique Ortega-Forte; Anna Rovira; Manel Bosch; Oriol Torres; Cristina Cuscó; Josep Rocas; José Ruiz; Vicente Marchán
Journal:  Biomacromolecules       Date:  2022-06-13       Impact factor: 6.978

2.  Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.

Authors:  Xuelei Yin; Yingying Chi; Chuanyou Guo; Shuaishuai Feng; Jinhu Liu; Kaoxiang Sun; Zimei Wu
Journal:  Pharm Res       Date:  2017-07-19       Impact factor: 4.200

3.  Core-Shell Nanoparticles as an Efficient, Sustained, and Triggered Drug-Delivery System.

Authors:  Sonal Deshpande; Sapna Sharma; Veena Koul; Neetu Singh
Journal:  ACS Omega       Date:  2017-10-06

Review 4.  Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy.

Authors:  Morgan E Lorkowski; Prabhani U Atukorale; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  Adv Healthc Mater       Date:  2020-11-23       Impact factor: 9.933

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.